Faster access than browser!Similarities between Bcr-Abl tyrosine-kinase inhibitor and Bosutinib
Bcr-Abl tyrosine-kinase inhibitor and Bosutinib have 7 things in common (in Unionpedia): Bcr-Abl tyrosine-kinase inhibitor, Chronic myelogenous leukemia, Food and Drug Administration, P-glycoprotein, Philadelphia chromosome, Src family kinase, Tyrosine-kinase inhibitor.
Bcr-Abl tyrosine-kinase inhibitor
Bcr-Abl tyrosine-kinase inhibitors (TKI) are the first-line therapy for most patients with chronic myelogenous leukemia (CML).
Bcr-Abl tyrosine-kinase inhibitor and Bcr-Abl tyrosine-kinase inhibitor · Bcr-Abl tyrosine-kinase inhibitor and Bosutinib ·
Chronic myelogenous leukemia
Chronic myelogenous leukemia (CML), also known as chronic myeloid leukemia, is a cancer of the white blood cells.
Bcr-Abl tyrosine-kinase inhibitor and Chronic myelogenous leukemia · Bosutinib and Chronic myelogenous leukemia ·
Food and Drug Administration
The Food and Drug Administration (FDA or USFDA) is a federal agency of the United States Department of Health and Human Services, one of the United States federal executive departments.
Bcr-Abl tyrosine-kinase inhibitor and Food and Drug Administration · Bosutinib and Food and Drug Administration ·
P-glycoprotein
P-glycoprotein 1 (permeability glycoprotein, abbreviated as P-gp or Pgp) also known as multidrug resistance protein 1 (MDR1) or ATP-binding cassette sub-family B member 1 (ABCB1) or cluster of differentiation 243 (CD243) is an important protein of the cell membrane that pumps many foreign substances out of cells.
Bcr-Abl tyrosine-kinase inhibitor and P-glycoprotein · Bosutinib and P-glycoprotein ·
Philadelphia chromosome
The Philadelphia chromosome or Philadelphia translocation (Ph) is a specific genetic abnormality in chromosome 22 of leukemia cancer cells (particularly chronic myeloid leukemia (CML) cells).
Bcr-Abl tyrosine-kinase inhibitor and Philadelphia chromosome · Bosutinib and Philadelphia chromosome ·
Src family kinase
Src kinase family is a family of non-receptor tyrosine kinases that includes nine members: Src, Yes, Fyn, and Fgr, forming the SrcA subfamily, Lck, Hck, Blk, and Lyn in the SrcB subfamily, and Frk in its own subfamily.
Bcr-Abl tyrosine-kinase inhibitor and Src family kinase · Bosutinib and Src family kinase ·
Tyrosine-kinase inhibitor
A tyrosine kinase inhibitor (TKI) is a pharmaceutical drug that inhibits tyrosine kinases.
Bcr-Abl tyrosine-kinase inhibitor and Tyrosine-kinase inhibitor · Bosutinib and Tyrosine-kinase inhibitor ·
The list above answers the following questions
- What Bcr-Abl tyrosine-kinase inhibitor and Bosutinib have in common
- What are the similarities between Bcr-Abl tyrosine-kinase inhibitor and Bosutinib
Bcr-Abl tyrosine-kinase inhibitor and Bosutinib Comparison
Bcr-Abl tyrosine-kinase inhibitor has 134 relations, while Bosutinib has 38. As they have in common 7, the Jaccard index is 4.07% = 7 / (134 + 38).
References
This article shows the relationship between Bcr-Abl tyrosine-kinase inhibitor and Bosutinib. To access each article from which the information was extracted, please visit:
